Stewart Appelrouth, Director at HEMISPHERX BIOPHARMA INC (HEB), bought 100,000 shares at $0.32 ($32K) on 2018-04-27, disclosed to the SEC on 2018-04-30.
Open-market purchase of $32k HEB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Clearly above the average filing.
| Filing → |
| AIM | BUY | 2024-03-18 | $30K | — | Filing → |
| AIM | BUY | 2023-01-04 | $25K | — | Filing → |
| AIM | BUY | 2021-02-25 | $25K | — | Filing → |